Published in Blood Weekly, May 31st, 2007
"Imatinib in combination with intensive chemotherapy has yielded promising results as front-line therapy, but its value...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.